| Non-sarcopenic (n = 1270) | Sarcopenic (n = 150) | p-value | ||
---|---|---|---|---|---|
CKD-EPI eGFR category | No sarcopenia (n = 1114) | Probable sarcopenia (n = 156) | Confirmed sarcopenia (n = 65) | Severe sarcopenia (n = 85) | |
≥90 (n = 42) | 37 (88.1%) | 5 (11.9%) | 0.774 | ||
29 (69.0%) | 8 (19.0%) | 3 (7.1%) | 2 (4.8%) | Â | |
60–89 (n = 884) | 795 (89.9%) | 89 (10.1%) | 0.435 | ||
720 (81.4%) | 75 (8.5%) | 46 (5.2%) | 43 (4.9%) | Â | |
45–59 (n = 247) | 226 (91.5%) | 21 (8.5%) | 0.246 | ||
194 (78.5%) | 32 (13.0%) | 5 (2.0%) | 16 (6.5%) | Â | |
30–44 (n = 163) | 139 (85.3%) | 24 (14.7%) | 0.066 | ||
112 (68.7%) | 27 (16.6%) | 9 (5.5%) | 15 (9.2%) | Â | |
15–29 (n = 84) | 73 (86.9%) | 11 (13.1%) | 0.436 | ||
59 (70.2%) | 14 (16.7%) | 2 (2.4%) | 9 (10.7%) | Â | |
≥60 (n = 1173) | 1058 (90.2%) | 115 (9.8%) | 0.042 | ||
943 (80.4%) | 115 (9.8%) | 54 (4.6%) | 61 (5.2%) | ||
< 60 (n = 247) | 212 (85.8%) | 35 (14.2%) | |||
171 (69.2%) | 41 (16.6%) | 11 (4.5%) | 24 (9.7%) |